Aytu Biopharma, Inc
AYTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385818
No open-market purchases or sales by Aytu Biopharma, Inc insiders were filed in the last 90 days; 38 institutions reported holding it in 13F filings for Q2 2026, worth $8.25M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Aytu Biopharma, Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +5 vs. Q4 2023
- Shares held
- 1.80M
- +26.2K (+1.5%) vs. Q4 2023
- Total value
- $5.46M
- +$433.4K (+8.6%) vs. Q4 2023
- New holders
- 6
- 6 more added
- Sold out
- 1
- 5 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AYTU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 38 | $8.25M |
| Q1 2026 | 37 | $10.7M |
| Q4 2025 | 39 | $9.81M |
| Q3 2025 | 33 | $6.73M |
| Q2 2025 | 32 | $7.45M |
| Q1 2025 | 31 | $2.49M |
| Q4 2024 | 29 | $3.19M |
| Q3 2024 | 24 | $4.81M |
| Q2 2024 | 27 | $5.99M |
| Q1 2024 | 27 | $5.46M |
| Q4 2023 | 22 | $5.02M |
| Q3 2023 | 22 | $4.65M |
| Q2 2023 | 21 | $2.73M |
| Q1 2023 | 21 | $1.21M |
| Q4 2022 | 42 | $1.52M |
| Q3 2022 | 53 | $1.64M |
| Q2 2022 | 41 | $2.50M |
| Q1 2022 | 44 | $6.02M |
| Q4 2021 | 46 | $5.10M |
| Q3 2021 | 49 | $12.2M |
| Q2 2021 | 61 | $26.0M |
| Q1 2021 | 72 | $48.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Aytu Biopharma, Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 1,086,812 | $3.30M | 0.32% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 472,469 | $1.44M | 1.14% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 71,323 | $217.0K | 0.00% | +2,400+3.5% | Added |
| Geode Capital Management, LLC | 34,563 | $105.1K | 0.00% | +1,517+4.6% | Added |
| Vanguard Group Inc | 27,888 | $84.8K | 0.00% | +637+2.3% | Added |
| BlackRock Inc. | 22,793 | $69.3K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 15,240 | $46.3K | 0.00% | +15,240 | New |
| Northern Trust Corp | 14,564 | $44.3K | 0.00% | −40.0% | Reduced |
| Acadian Asset Management LLC | 14,622 | $44.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 13,882 | $42.2K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 12,175 | $37.0K | 0.00% | +12,175 | New |
| Tower Research Capital LLC (TRC) | 3,026 | $9.20K | 0.00% | +743+32.5% | Added |
| Royal Bank of Canada | 2,709 | $8.00K | 0.00% | −890−24.7% | Reduced |
| Morgan Stanley | 1,060 | $3.22K | 0.00% | −340−24.3% | Reduced |
| UBS Group AG | 1,026 | $3.12K | 0.00% | +766+294.6% | Added |
| JPMorgan Chase & Co | 620 | $1.89K | 0.00% | −6,215−90.9% | Reduced |
| Advisor Group Holdings, Inc. | 300 | $912 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 164 | $498 | 0.00% | −7−4.1% | Reduced |
| CIBC Private Wealth Group, LLC | 83 | $248 | 0.00% | +83 | New |
| Bank of America Corp | 50 | $152 | 0.00% | +50 | New |
| Group One Trading, L.P. | 37 | $112 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 21 | $64 | 0.00% | 00.0% | Unchanged |
| Huntington National Bank | 20 | $61 | 0.00% | +20 | New |
| West Financial Advisors, LLC | 10 | $31 | 0.00% | +10 | New |
| CarsonAllaria Wealth Management, Ltd. | 5 | $15 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 2 | $6 | 0.00% | +1+100.0% | Added |
| TSFG, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |